Peptide Loss After Dilution: How to Test for Surface Adsorption

Peptide loss after dilution can occur when molecules adsorb to tubes, pipette tips or sample vials. To investigate it, compare controlled handling paths while keeping concentration, buffer, volume and total holding time consistent. A clear solution does not establish that the intended peptide concentration remains available.

This guide describes a practical recovery comparison for research laboratories. It focuses on handling after dissolution. If the starting material has not dissolved, begin with our guide to dissolving and reconstituting lyophilized peptides.

Why Peptide Recovery Can Change After Dilution

Surface adsorption depends on the peptide, contacted material and solution conditions. A satisfactory concentrated stock therefore does not establish that a diluted working solution will behave similarly.

Kristensen and colleagues measured recovery of three cationic membrane-active peptides: mastoparan X, melittin and magainin 2. At lower concentrations, ordinary glass and polypropylene containers produced substantial losses, while Protein LoBind tubes generally improved recovery under the conditions tested. The magnitude varied with peptide and concentration. [1]

Figure 1. Concentration-dependent peptide recovery in different containers. Panels show mastoparan X (A), melittin (B) and magainin 2 (C). Samples contained 220 µL of peptide solution at 1–20 µM in 10 mM HEPES, 100 mM NaCl, pH 7.4, and were incubated for one hour. Points represent the mean of two separate experiments; error bars show standard deviations. Reproduced from Figure 3 of Kristensen et al. [1], © 2015 the authors, under CC BY 4.0. Image format converted; data and panels unchanged.

We recommend evaluating recovery at the intended working concentration. Results for these three peptides illustrate a handling risk, not a universal prediction for every sequence.

A 2025 study provides complementary evidence from HeLa tryptic digests. It found preferential adsorption of certain peptides, particularly hydrophobic ones, to polypropylene vials. This nonuniform loss affected the composition of the measured mixture. A digest differs from a purified synthetic peptide solution, but the findings reinforce the need to qualify materials for the actual sample. [3]

Separate Low Recovery From Low Activity

A weak assay response can have several explanations. Before changing the preparation, identify what the measurement actually establishes.

Use a quantitative method suitable for the peptide and concentration. HPLC or LC–MS may be appropriate when selectivity, response range and precision have been established. A biological response alone is insufficient to measure peptide recovery.

Design a Controlled Recovery Test

The comparison below is a proposed troubleshooting design, not a universally validated protocol. Adapt it to your peptide and analytical method.

Start with one homogeneous stock. Record the peptide identity, modifications, salt form, lot, concentration basis and solvent. Check dilution calculations before testing new materials.

Choose the intended working concentration and one higher comparison concentration within the analytical method’s qualified range. Prepare each independently from the same stock or a qualified intermediate; do not prepare one test condition from another.

Figure 2. Proposed comparison of preparation tube choice and additional handling. Compare A with B to investigate tube choice, and B with C to investigate extra transfers. Keep total holding time equal across paths, including time spent in intermediate containers. This schematic describes an experimental design; it does not show measured results.

Compare Three Handling Paths

Path A — Routine handling. Prepare the working solution in the current tube and transfer it once to the final analytical vial.

Path B — Alternative preparation tube. Use a candidate low-binding tube, followed by one transfer to the same final vial type used in path A.

Path C — Additional transfers. Use the same preparation tube type as path B, but make three transfers in total: two between preparation tubes and one into the final analytical vial.

Keep the pipette tip type, starting volume, solution composition and final analytical vial type constant. This first experiment tests preparation tube choice and the effect of additional handling. It does not independently establish the contribution of tips or the final vial.

Three independent preparations per path at each of two concentrations give 18 test preparations, plus reference samples, blanks and instrument controls. This is a practical starting design, not a mandatory replicate count.

Repeated injections of one preparation assess injection repeatability. They do not replace independent preparation replicates.

Keep Holding Time Comparable

Select a total holding period that represents the delay in your actual workflow. Keep it equal across all three paths.

For path C, divide that period between the intermediate containers. Do not add extra waiting time simply because there are more transfers. Otherwise, the experiment confounds transfer count with time.

Also record the interval between filling the analytical vial and injection. Balance injection order and include quality controls so that instrument drift or an autosampler queue does not become an unnoticed experimental variable.

We recommend changing the handling path before changing solvent composition. This makes the first comparison easier to interpret.

Calculate Relative Recovery

Prepare matched, minimally handled reference samples at the same nominal concentrations and in the same final matrix. Establish that their preparation is reproducible.

For equal nominal concentrations:

Relative recovery (%) = measured sample concentration ÷ measured reference concentration × 100

For example, if the reference measures 0.95 µM and the routinely handled sample measures 0.62 µM:

Relative recovery = 0.62 ÷ 0.95 × 100 = 65.3%

These values are a calculation example, not experimental results from Alan Scientific.

A reference can also lose peptide. This calculation therefore measures recovery relative to that reference preparation; it does not prove the absolute fraction remaining from the original weighed material.

If using peak-area ratios, first establish that response is linear and that matrix, injection volume and analytical conditions are comparable. Report preparation-to-preparation variability alongside the mean.

Define acceptable recovery and precision from the intended use. Do not apply an arbitrary universal cutoff to every assay.

Interpret the Pattern Before Selecting a Fix

These patterns help prioritize follow-up work. They do not, on their own, prove adsorption.

Stronger evidence may require extracting peptide from the contacted surface using a qualified procedure and assessing mass balance. Likewise, the absence of new chromatographic peaks does not exclude degradation if the method cannot detect or resolve the products.

Check the Final Vial as Well as the Preparation Tube

A successful preparation tube comparison does not qualify the whole contact path.

Murphy and colleagues compared regular and low-binding preparation tubes and LC vials for the synthetic peptide Vn96. At 10 pg/µL, using low-binding materials throughout produced the strongest observed signal. Their work demonstrates why changing only one container can leave an important loss mechanism unresolved. [2]

We treat “low-binding” as a candidate specification that requires verification for the intended use. Record the supplier, product number and fill volume so that a successful condition can be reproduced.

After identifying a promising change, confirm it in the complete workflow, including the final assay plate or analytical destination.

Test Additives Separately

Carrier proteins, surfactants and organic modifiers can affect both sample recovery and the measurement itself.

In the Vn96 and protein study, an added protein could compete for adsorption sites, but the authors also explained why BSA would interfere with their intact apomyoglobin measurement. A useful additive for one method can compromise another. [2]

If testing an additive, include an additive-only blank, matched references and checks for analytical interference. In a biological assay, establish that the additive does not independently change the endpoint.

Avoid importing an additive concentration from an unrelated method without evaluating the final sample and assay conditions.

Keep a Handling Record With the Result

Document peptide identity and lot, concentration basis, dilution scheme, solution composition, tube and tip specifications, transfer count, temperature, holding time and measured recovery.

This record makes repeat experiments and technical discussions more useful. It also helps distinguish a handling difference from a batch difference.

When discussing a custom peptide synthesis project, include the intended working concentration, assay matrix and any observed handling difficulties alongside sequence, quantity, purity and modification requirements.

References

1. Kristensen K, Henriksen JR, Andresen TL. Adsorption of Cationic Peptides to Solid Surfaces of Glass and Plastic. PLOS ONE. 2015;10(5). https://doi.org/10.1371/journal.pone.0122419

2. Murphy EL, Joy AP, Ouellette RJ, Barnett DA. Improved intact peptide and protein quantitation by LC-MS: Battling the deleterious effects of analyte adsorption. Analytical Science Advances. 2021;2(5–6):299–307. First published online October 7, 2020. https://doi.org/10.1002/ansa.202000102

3. Kune C, Tielens S, Baiwir D, Fléron M, Vandormael D, Eppe G, Nguyen L, Mazzucchelli G. Significant Impact of Consumable Material and Buffer Composition for Low-Cell Number Proteomic Sample Preparation. Analytical Chemistry. 2025;97:3836–3845. https://doi.org/10.1021/acs.analchem.4c03709